SEDANA Stock Overview
A medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Sedana Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 10.70 |
| 52 Week High | SEK 28.60 |
| 52 Week Low | SEK 10.40 |
| Beta | 0.42 |
| 11 Month Change | -53.17% |
| 3 Month Change | -53.98% |
| 1 Year Change | -37.06% |
| 33 Year Change | -88.22% |
| 5 Year Change | -66.56% |
| Change since IPO | 79.83% |
Recent News & Updates
Recent updates
kr34.00: That's What Analysts Think Sedana Medical AB (publ) (STO:SEDANA) Is Worth After Its Latest Results
Oct 28
Sedana Medical AB (publ)'s (STO:SEDANA) 36% Cheaper Price Remains In Tune With Revenues
Oct 25After Leaping 27% Sedana Medical AB (publ) (STO:SEDANA) Shares Are Not Flying Under The Radar
Jun 07Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Apr 28Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation
Mar 16Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking
Dec 21We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely
Oct 29Sedana Medical (STO:SEDANA) Is In A Good Position To Deliver On Growth Plans
Jul 12Analysts Just Made A Major Revision To Their Sedana Medical AB (publ) (STO:SEDANA) Revenue Forecasts
May 01We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely
Feb 17Analysts Are More Bearish On Sedana Medical AB (publ) (STO:SEDANA) Than They Used To Be
Jan 20Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation
Oct 05Companies Like Sedana Medical (STO:SEDANA) Are In A Position To Invest In Growth
Jul 05Sedana Medical AB (publ) (STO:SEDANA) Analysts Just Slashed This Year's Estimates
May 03Shareholder Returns
| SEDANA | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -16.8% | -4.0% | -3.6% |
| 1Y | -37.1% | -3.9% | 12.3% |
Return vs Industry: SEDANA underperformed the Swedish Medical Equipment industry which returned -2% over the past year.
Return vs Market: SEDANA underperformed the Swedish Market which returned 13.4% over the past year.
Price Volatility
| SEDANA volatility | |
|---|---|
| SEDANA Average Weekly Movement | 10.9% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: SEDANA's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: SEDANA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 78 | Johannes Doll | www.sedanamedical.com |
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; and Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care, as well as AnaConDa, a medical device enabling administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; Scavenging tube, a one piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables to connect the exhaust of the ventilator to an active or passive scavenging system.
Sedana Medical AB (publ) Fundamentals Summary
| SEDANA fundamental statistics | |
|---|---|
| Market cap | SEK 1.06b |
| Earnings (TTM) | -SEK 57.24m |
| Revenue (TTM) | SEK 174.14m |
6.1x
P/S Ratio-18.6x
P/E RatioIs SEDANA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SEDANA income statement (TTM) | |
|---|---|
| Revenue | SEK 174.14m |
| Cost of Revenue | SEK 51.20m |
| Gross Profit | SEK 122.95m |
| Other Expenses | SEK 180.19m |
| Earnings | -SEK 57.24m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | -0.58 |
| Gross Margin | 70.60% |
| Net Profit Margin | -32.87% |
| Debt/Equity Ratio | 0% |
How did SEDANA perform over the long term?
See historical performance and comparison